Biosig Technologies (BSGM) Competitors $3.81 -0.21 (-5.22%) Closing price 08/6/2025 04:00 PM EasternExtended Trading$3.89 +0.08 (+2.20%) As of 07:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock BSGM vs. ZIMV, BFLY, DCTH, TMCI, OM, SNWV, RXST, CLPT, CATX, and NNOXShould you be buying Biosig Technologies stock or one of its competitors? The main competitors of Biosig Technologies include ZimVie (ZIMV), Butterfly Network (BFLY), Delcath Systems (DCTH), Treace Medical Concepts (TMCI), Outset Medical (OM), Sanuwave Health (SNWV), RxSight (RXST), ClearPoint Neuro (CLPT), Perspective Therapeutics (CATX), and Nano-X Imaging (NNOX). These companies are all part of the "medical equipment" industry. Biosig Technologies vs. Its Competitors ZimVie Butterfly Network Delcath Systems Treace Medical Concepts Outset Medical Sanuwave Health RxSight ClearPoint Neuro Perspective Therapeutics Nano-X Imaging Biosig Technologies (NASDAQ:BSGM) and ZimVie (NASDAQ:ZIMV) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, media sentiment, valuation, dividends, profitability, analyst recommendations and institutional ownership. Which has stronger valuation and earnings, BSGM or ZIMV? Biosig Technologies has higher earnings, but lower revenue than ZimVie. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiosig Technologies$26K3,999.77-$10.33MN/AN/AZimVie$449.75M1.18-$25.83M-$0.70-26.89 Do institutionals & insiders believe in BSGM or ZIMV? 7.2% of Biosig Technologies shares are owned by institutional investors. Comparatively, 95.6% of ZimVie shares are owned by institutional investors. 17.0% of Biosig Technologies shares are owned by company insiders. Comparatively, 3.0% of ZimVie shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more volatility & risk, BSGM or ZIMV? Biosig Technologies has a beta of 1.65, meaning that its stock price is 65% more volatile than the S&P 500. Comparatively, ZimVie has a beta of 2.2, meaning that its stock price is 120% more volatile than the S&P 500. Do analysts prefer BSGM or ZIMV? Biosig Technologies currently has a consensus price target of $10.00, indicating a potential upside of 162.47%. ZimVie has a consensus price target of $17.75, indicating a potential downside of 5.69%. Given Biosig Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Biosig Technologies is more favorable than ZimVie.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biosig Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00ZimVie 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is BSGM or ZIMV more profitable? Biosig Technologies has a net margin of 0.00% compared to ZimVie's net margin of -4.39%. ZimVie's return on equity of 6.37% beat Biosig Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Biosig TechnologiesN/A -5,336.99% -398.16% ZimVie -4.39%6.37%3.34% Does the media prefer BSGM or ZIMV? In the previous week, ZimVie had 3 more articles in the media than Biosig Technologies. MarketBeat recorded 6 mentions for ZimVie and 3 mentions for Biosig Technologies. ZimVie's average media sentiment score of 0.48 beat Biosig Technologies' score of 0.22 indicating that ZimVie is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biosig Technologies 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral ZimVie 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryBiosig Technologies and ZimVie tied by winning 7 of the 14 factors compared between the two stocks. Get Biosig Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BSGM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BSGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BSGM vs. The Competition Export to ExcelMetricBiosig TechnologiesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$109.73M$6.94B$5.57B$9.47BDividend YieldN/A1.34%4.31%4.18%P/E RatioN/A20.6229.4123.99Price / Sales3,999.7772.05445.35187.89Price / CashN/A20.8935.8458.51Price / Book-42.335.558.075.58Net Income-$10.33M$178.18M$3.26B$265.35M7 Day Performance-17.53%-0.39%0.45%-0.07%1 Month Performance-67.01%-2.58%4.83%1.76%1 Year Performance902.90%11.78%30.22%25.39% Biosig Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BSGMBiosig Technologies2.2132 of 5 stars$3.81-5.2%$10.00+162.5%+929.7%$109.73M$26K0.0050Upcoming EarningsZIMVZimVie0.9159 of 5 stars$18.82+0.5%$17.00-9.7%+9.7%$521.30M$449.75M-26.511,770BFLYButterfly Network2.4021 of 5 stars$1.93-2.0%$3.50+81.3%+38.9%$487.16M$82.06M-6.66460Earnings ReportAnalyst ForecastGap UpDCTHDelcath Systems3.0417 of 5 stars$11.41flat$24.00+110.3%+34.5%$397.37M$37.21M-22.8260News CoverageTMCITreace Medical Concepts2.1866 of 5 stars$5.75+0.9%$10.52+82.9%-17.9%$358.47M$209.36M-6.76250Positive NewsOMOutset Medical1.8748 of 5 stars$18.04-2.6%$29.50+63.5%-75.1%$328.39M$115.27M-0.62520News CoverageSNWVSanuwave Health2.2463 of 5 stars$35.75-5.6%N/AN/A$324.43M$32.63M-7.8540RXSTRxSight3.2975 of 5 stars$7.87-1.3%$17.50+122.4%-84.2%$323.88M$139.93M-11.75220Trending NewsCLPTClearPoint Neuro2.8413 of 5 stars$10.97-2.3%$25.00+127.9%+61.8%$314.32M$31.39M-14.43110News CoveragePositive NewsUpcoming EarningsCATXPerspective Therapeutics2.518 of 5 stars$4.12+1.5%$12.56+204.7%-69.1%$305.82MN/A0.0070News CoverageUpcoming EarningsNNOXNano-X Imaging1.9576 of 5 stars$5.14-1.2%$9.50+84.8%-35.6%$300.45M$11.28M-5.71190News CoverageUpcoming Earnings Related Companies and Tools Related Companies ZimVie Competitors Butterfly Network Competitors Delcath Systems Competitors Treace Medical Concepts Competitors Outset Medical Competitors Sanuwave Health Competitors RxSight Competitors ClearPoint Neuro Competitors Perspective Therapeutics Competitors Nano-X Imaging Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BSGM) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biosig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biosig Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
